Iridex reaffirms FY2026 sales guidance at $51M–$53M
Iridex (NASDAQ: IRIX) affirms FY2026 sales outlook of $51.000M–$53.000M versus a $53.227M estimate, keeping guidance unchanged in the stated range.
Iridex (NASDAQ: IRIX ) affirms FY2026 sales outlook from $51.000 million-$53.000 million to $51.000 million-$53.000 million vs $53.227 million estimate.